Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children
Cefotaxime and other cephalosporins were retrospectively evaluated for the treatment of meningitis and non-central nervous system (CNS) infections due to ampicillin-resistant Haemophilus influenzae type b (Hib). Between January 1985 and February 1989, 45 cases of meningitis and 27 cases of non-CNS i...
Gespeichert in:
| Veröffentlicht in: | Reviews of infectious diseases 1991-03, Vol.13 (2), p.197-200 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 200 |
|---|---|
| container_issue | 2 |
| container_start_page | 197 |
| container_title | Reviews of infectious diseases |
| container_volume | 13 |
| creator | Jesus G. Vallejo Kaplan, Sheldon L. Edward O. Mason, Jr |
| description | Cefotaxime and other cephalosporins were retrospectively evaluated for the treatment of meningitis and non-central nervous system (CNS) infections due to ampicillin-resistant Haemophilus influenzae type b (Hib). Between January 1985 and February 1989, 45 cases of meningitis and 27 cases of non-CNS infection due to ampicillin-resistant Hib were documented at Texas Children's Hospital in Houston. Of the 45 children with meningitis, 26 (57.8%) were treated with cefotaxime, 11 (24.4%) with chloramphenicol, and three (6.7%) with cefuroxime; five children (11.1%) were initially given chloramphenicol but later received cefotaxime instead. In addition, 14 chloramphenicol-treated patients from a previous study were included in this analysis. There were no significant differences in terms of neurologic sequelae or other complications (except diarrhea) between the cefotaxime and chloramphenicol groups. The efficacy of cefotaxime was equivalent to that of chloramphenicol for the treatment of ampicillin-resistant Hib meningitis. Cefuroxime was as safe and effective as chloramphenicol or cefotaxime for the treatment of non-CNS infections due to ampicillin-resistant Hib. |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_80601041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4455839</jstor_id><sourcerecordid>4455839</sourcerecordid><originalsourceid>FETCH-LOGICAL-j288t-2be404d5739002930a609f98a0ff79cb8c520dbe5739eb183db01229fe4e5fb53</originalsourceid><addsrcrecordid>eNqF0D1PwzAQgOEMoFIK_wAkL7BFsh07sceqfLRSUSVU5shOztRV4gTbGcqvJ1Wrrkwn-X18w10lU0xymmIh8pvkNoQ9xjwrWD5JJhQzIpmYJn7rQcUWXESdQR_grPu20QakXI02cQcerZyBKtrOBfQyAIodmre9rWzTWJd-QrAhqvH7UkHb9TvbDAFZZ5oB3K8CtD30gPT4ghZjqz24u-TaqCbA_XnOkq-31-1ima4376vFfJ3uqRAxpRoYZjUvMokxlRlWOZZGCoWNKWSlRcUprjUcAWgislpjQqk0wIAbzbNZ8nza2_vuZ4AQy9aGCppGOeiGUAqcYzLe4V9IuBS5JPkIH89w0C3UZe9tq_yhPF9z7E_nrkKlGuOVq2y4MCILybk4uoeT24fY-UtnbKyZzP4A8niG0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15986916</pqid></control><display><type>article</type><title>Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><creator>Jesus G. Vallejo ; Kaplan, Sheldon L. ; Edward O. Mason, Jr</creator><creatorcontrib>Jesus G. Vallejo ; Kaplan, Sheldon L. ; Edward O. Mason, Jr</creatorcontrib><description>Cefotaxime and other cephalosporins were retrospectively evaluated for the treatment of meningitis and non-central nervous system (CNS) infections due to ampicillin-resistant Haemophilus influenzae type b (Hib). Between January 1985 and February 1989, 45 cases of meningitis and 27 cases of non-CNS infection due to ampicillin-resistant Hib were documented at Texas Children's Hospital in Houston. Of the 45 children with meningitis, 26 (57.8%) were treated with cefotaxime, 11 (24.4%) with chloramphenicol, and three (6.7%) with cefuroxime; five children (11.1%) were initially given chloramphenicol but later received cefotaxime instead. In addition, 14 chloramphenicol-treated patients from a previous study were included in this analysis. There were no significant differences in terms of neurologic sequelae or other complications (except diarrhea) between the cefotaxime and chloramphenicol groups. The efficacy of cefotaxime was equivalent to that of chloramphenicol for the treatment of ampicillin-resistant Hib meningitis. Cefuroxime was as safe and effective as chloramphenicol or cefotaxime for the treatment of non-CNS infections due to ampicillin-resistant Hib.</description><identifier>ISSN: 0162-0886</identifier><identifier>PMID: 2041948</identifier><identifier>CODEN: RINDDG</identifier><language>eng</language><publisher>Chicago, IL: University of Chicago Press</publisher><subject>Ampicillin Resistance ; Antibacterial agents ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Arthritis, Infectious - drug therapy ; Bacterial meningitis ; Biological and medical sciences ; Cefotaxime - therapeutic use ; Cefuroxime - therapeutic use ; Cellulitis - drug therapy ; Child health services ; Children ; Chloramphenicol - therapeutic use ; Clinical Infectious Disease Articles ; Epiglottitis - drug therapy ; Fever ; Haemophilus Infections - drug therapy ; Haemophilus influenzae - drug effects ; Haemophilus influenzae type b ; Haemophilus meningitis ; Hearing Loss, Bilateral - etiology ; Hospital admissions ; Humans ; Infant ; Infections ; Medical sciences ; Meningitis ; Meningitis, Haemophilus - complications ; Meningitis, Haemophilus - drug therapy ; Pharmacology. Drug treatments ; Pneumonia - drug therapy ; Retrospective Studies ; Sepsis - drug therapy ; Subdural Effusion - etiology</subject><ispartof>Reviews of infectious diseases, 1991-03, Vol.13 (2), p.197-200</ispartof><rights>Copyright 1991 The University of Chicago</rights><rights>1991 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4455839$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4455839$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,777,781,800,57998,58231</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19795588$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2041948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jesus G. Vallejo</creatorcontrib><creatorcontrib>Kaplan, Sheldon L.</creatorcontrib><creatorcontrib>Edward O. Mason, Jr</creatorcontrib><title>Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children</title><title>Reviews of infectious diseases</title><addtitle>Rev Infect Dis</addtitle><description>Cefotaxime and other cephalosporins were retrospectively evaluated for the treatment of meningitis and non-central nervous system (CNS) infections due to ampicillin-resistant Haemophilus influenzae type b (Hib). Between January 1985 and February 1989, 45 cases of meningitis and 27 cases of non-CNS infection due to ampicillin-resistant Hib were documented at Texas Children's Hospital in Houston. Of the 45 children with meningitis, 26 (57.8%) were treated with cefotaxime, 11 (24.4%) with chloramphenicol, and three (6.7%) with cefuroxime; five children (11.1%) were initially given chloramphenicol but later received cefotaxime instead. In addition, 14 chloramphenicol-treated patients from a previous study were included in this analysis. There were no significant differences in terms of neurologic sequelae or other complications (except diarrhea) between the cefotaxime and chloramphenicol groups. The efficacy of cefotaxime was equivalent to that of chloramphenicol for the treatment of ampicillin-resistant Hib meningitis. Cefuroxime was as safe and effective as chloramphenicol or cefotaxime for the treatment of non-CNS infections due to ampicillin-resistant Hib.</description><subject>Ampicillin Resistance</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Arthritis, Infectious - drug therapy</subject><subject>Bacterial meningitis</subject><subject>Biological and medical sciences</subject><subject>Cefotaxime - therapeutic use</subject><subject>Cefuroxime - therapeutic use</subject><subject>Cellulitis - drug therapy</subject><subject>Child health services</subject><subject>Children</subject><subject>Chloramphenicol - therapeutic use</subject><subject>Clinical Infectious Disease Articles</subject><subject>Epiglottitis - drug therapy</subject><subject>Fever</subject><subject>Haemophilus Infections - drug therapy</subject><subject>Haemophilus influenzae - drug effects</subject><subject>Haemophilus influenzae type b</subject><subject>Haemophilus meningitis</subject><subject>Hearing Loss, Bilateral - etiology</subject><subject>Hospital admissions</subject><subject>Humans</subject><subject>Infant</subject><subject>Infections</subject><subject>Medical sciences</subject><subject>Meningitis</subject><subject>Meningitis, Haemophilus - complications</subject><subject>Meningitis, Haemophilus - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Pneumonia - drug therapy</subject><subject>Retrospective Studies</subject><subject>Sepsis - drug therapy</subject><subject>Subdural Effusion - etiology</subject><issn>0162-0886</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0D1PwzAQgOEMoFIK_wAkL7BFsh07sceqfLRSUSVU5shOztRV4gTbGcqvJ1Wrrkwn-X18w10lU0xymmIh8pvkNoQ9xjwrWD5JJhQzIpmYJn7rQcUWXESdQR_grPu20QakXI02cQcerZyBKtrOBfQyAIodmre9rWzTWJd-QrAhqvH7UkHb9TvbDAFZZ5oB3K8CtD30gPT4ghZjqz24u-TaqCbA_XnOkq-31-1ima4376vFfJ3uqRAxpRoYZjUvMokxlRlWOZZGCoWNKWSlRcUprjUcAWgislpjQqk0wIAbzbNZ8nza2_vuZ4AQy9aGCppGOeiGUAqcYzLe4V9IuBS5JPkIH89w0C3UZe9tq_yhPF9z7E_nrkKlGuOVq2y4MCILybk4uoeT24fY-UtnbKyZzP4A8niG0w</recordid><startdate>19910301</startdate><enddate>19910301</enddate><creator>Jesus G. Vallejo</creator><creator>Kaplan, Sheldon L.</creator><creator>Edward O. Mason, Jr</creator><general>University of Chicago Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19910301</creationdate><title>Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children</title><author>Jesus G. Vallejo ; Kaplan, Sheldon L. ; Edward O. Mason, Jr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j288t-2be404d5739002930a609f98a0ff79cb8c520dbe5739eb183db01229fe4e5fb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Ampicillin Resistance</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Arthritis, Infectious - drug therapy</topic><topic>Bacterial meningitis</topic><topic>Biological and medical sciences</topic><topic>Cefotaxime - therapeutic use</topic><topic>Cefuroxime - therapeutic use</topic><topic>Cellulitis - drug therapy</topic><topic>Child health services</topic><topic>Children</topic><topic>Chloramphenicol - therapeutic use</topic><topic>Clinical Infectious Disease Articles</topic><topic>Epiglottitis - drug therapy</topic><topic>Fever</topic><topic>Haemophilus Infections - drug therapy</topic><topic>Haemophilus influenzae - drug effects</topic><topic>Haemophilus influenzae type b</topic><topic>Haemophilus meningitis</topic><topic>Hearing Loss, Bilateral - etiology</topic><topic>Hospital admissions</topic><topic>Humans</topic><topic>Infant</topic><topic>Infections</topic><topic>Medical sciences</topic><topic>Meningitis</topic><topic>Meningitis, Haemophilus - complications</topic><topic>Meningitis, Haemophilus - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Pneumonia - drug therapy</topic><topic>Retrospective Studies</topic><topic>Sepsis - drug therapy</topic><topic>Subdural Effusion - etiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Jesus G. Vallejo</creatorcontrib><creatorcontrib>Kaplan, Sheldon L.</creatorcontrib><creatorcontrib>Edward O. Mason, Jr</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Reviews of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jesus G. Vallejo</au><au>Kaplan, Sheldon L.</au><au>Edward O. Mason, Jr</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children</atitle><jtitle>Reviews of infectious diseases</jtitle><addtitle>Rev Infect Dis</addtitle><date>1991-03-01</date><risdate>1991</risdate><volume>13</volume><issue>2</issue><spage>197</spage><epage>200</epage><pages>197-200</pages><issn>0162-0886</issn><coden>RINDDG</coden><abstract>Cefotaxime and other cephalosporins were retrospectively evaluated for the treatment of meningitis and non-central nervous system (CNS) infections due to ampicillin-resistant Haemophilus influenzae type b (Hib). Between January 1985 and February 1989, 45 cases of meningitis and 27 cases of non-CNS infection due to ampicillin-resistant Hib were documented at Texas Children's Hospital in Houston. Of the 45 children with meningitis, 26 (57.8%) were treated with cefotaxime, 11 (24.4%) with chloramphenicol, and three (6.7%) with cefuroxime; five children (11.1%) were initially given chloramphenicol but later received cefotaxime instead. In addition, 14 chloramphenicol-treated patients from a previous study were included in this analysis. There were no significant differences in terms of neurologic sequelae or other complications (except diarrhea) between the cefotaxime and chloramphenicol groups. The efficacy of cefotaxime was equivalent to that of chloramphenicol for the treatment of ampicillin-resistant Hib meningitis. Cefuroxime was as safe and effective as chloramphenicol or cefotaxime for the treatment of non-CNS infections due to ampicillin-resistant Hib.</abstract><cop>Chicago, IL</cop><pub>University of Chicago Press</pub><pmid>2041948</pmid><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0162-0886 |
| ispartof | Reviews of infectious diseases, 1991-03, Vol.13 (2), p.197-200 |
| issn | 0162-0886 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_80601041 |
| source | MEDLINE; Jstor Complete Legacy |
| subjects | Ampicillin Resistance Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Arthritis, Infectious - drug therapy Bacterial meningitis Biological and medical sciences Cefotaxime - therapeutic use Cefuroxime - therapeutic use Cellulitis - drug therapy Child health services Children Chloramphenicol - therapeutic use Clinical Infectious Disease Articles Epiglottitis - drug therapy Fever Haemophilus Infections - drug therapy Haemophilus influenzae - drug effects Haemophilus influenzae type b Haemophilus meningitis Hearing Loss, Bilateral - etiology Hospital admissions Humans Infant Infections Medical sciences Meningitis Meningitis, Haemophilus - complications Meningitis, Haemophilus - drug therapy Pharmacology. Drug treatments Pneumonia - drug therapy Retrospective Studies Sepsis - drug therapy Subdural Effusion - etiology |
| title | Treatment of Meningitis and Other Infections Due to Ampicillin-Resistant Haemophilus influenzae Type b in Children |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T03%3A22%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Meningitis%20and%20Other%20Infections%20Due%20to%20Ampicillin-Resistant%20Haemophilus%20influenzae%20Type%20b%20in%20Children&rft.jtitle=Reviews%20of%20infectious%20diseases&rft.au=Jesus%20G.%20Vallejo&rft.date=1991-03-01&rft.volume=13&rft.issue=2&rft.spage=197&rft.epage=200&rft.pages=197-200&rft.issn=0162-0886&rft.coden=RINDDG&rft_id=info:doi/&rft_dat=%3Cjstor_proqu%3E4455839%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15986916&rft_id=info:pmid/2041948&rft_jstor_id=4455839&rfr_iscdi=true |